Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.355
-0.045 (-3.21%)
At close: Aug 1, 2025, 4:00 PM
1.350
-0.005 (-0.37%)
After-hours: Aug 1, 2025, 4:10 PM EDT

Vista Outdoor Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Net Income
-116.25-102.33-52.37-42.86-100.61-7.33
Upgrade
Depreciation & Amortization
0.180.180.180.170-
Upgrade
Asset Writedown & Restructuring Costs
--0.74---
Upgrade
Loss (Gain) From Sale of Investments
-3.94-5.11-3.130.490.16-
Upgrade
Stock-Based Compensation
9.639.646.153.060.920.15
Upgrade
Other Operating Activities
-0.45-0.241.51-81.27-0.59
Upgrade
Change in Accounts Receivable
------0.08
Upgrade
Change in Accounts Payable
-2.024.27-0.260.550.560.31
Upgrade
Change in Other Net Operating Assets
10.387.384.133.43-0.260.08
Upgrade
Operating Cash Flow
-102.48-86.22-43.06-35.15-17.96-7.45
Upgrade
Capital Expenditures
-0.08-0.02-0.02-0.16-0.04-
Upgrade
Sale of Property, Plant & Equipment
--0---
Upgrade
Investment in Securities
8648.04-171.6539.35-104.08-
Upgrade
Investing Cash Flow
85.9248.03-171.6739.19-104.12-
Upgrade
Long-Term Debt Issued
--30---
Upgrade
Long-Term Debt Repaid
--0.74----
Upgrade
Net Debt Issued (Repaid)
--0.7430---
Upgrade
Issuance of Common Stock
0.047.94122.233.91169.19-
Upgrade
Repurchase of Common Stock
-0.08-0.04----
Upgrade
Other Financing Activities
-0.17-0.23-0.48---
Upgrade
Financing Cash Flow
-0.226.93151.753.91200.4744.68
Upgrade
Net Cash Flow
-16.77-31.26-62.987.9478.3937.23
Upgrade
Free Cash Flow
-102.56-86.23-43.09-35.31-18-7.45
Upgrade
Free Cash Flow Margin
------518.80%
Upgrade
Free Cash Flow Per Share
-1.70-1.44-0.89-0.87-0.90-17.77
Upgrade
Cash Interest Paid
2.942.970.17---
Upgrade
Levered Free Cash Flow
-63.62-52.29-28.24-20.94-16.350.21
Upgrade
Unlevered Free Cash Flow
-61.07-49.75-27.87-20.94-16.350.21
Upgrade
Change in Net Working Capital
-8.35-11.71-4.03-4.264.99-5
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q